REGN
56
6
UPS
45
2
NUE
51
3
CMA
53
3
EQT
57
7
PVH
53
3
LNC
62
4
AMGN
46
15
KHC
45
5
AEE
56
3
URI
66
3
ZTS
40
2
MDT
62
2
EA
42
3
C
65
4
VMC
47
5
SYF
83
5
NSC
60
4
HST
62
3
MDLZ
26
-2
REGN
56
6
UPS
45
2
NUE
51
3
CMA
53
3
EQT
57
7
PVH
53
3
LNC
62
4
AMGN
46
15
KHC
45
5
AEE
56
3
URI
66
3
ZTS
40
2
MDT
62
2
EA
42
3
C
65
4
VMC
47
5
SYF
83
5
NSC
60
4
HST
62
3
MDLZ
26
-2
Financhill
Back

Corcept Therapeutics Quote, Financials, Valuation and Earnings

Multimillionaire Trader Reveals His #1 Gold Pick

Click here to learn more about this game-changing opportunity.
Buy
74

CORT
Corcept Therapeutics

Last Price:
45.43
Seasonality Move:
11.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Unlock the Ultimate Gold Play: $20 for a 1 Oz Stake in Gold!

Don't miss out-click here for urgent details on the #1 gold play of the year!

Corcept Therapeutics Price Quote

$45.43

Corcept Therapeutics Key Stats

Buy
74
Corcept Therapeutics (CORT) is a Buy
Day range:
$45.04 - $46.17
52-week range:
$20.84 - $47.71
Dividend yield:
0%
P/E ratio:
48.33
P/S ratio:
8.83
P/B ratio:
7.96%
Volume:
713.2K
Avg. volume:
848.1K
1-year change:
64.66%
Market cap:
$4.7B
Revenue:
$482.4M
EPS:
$1.13

How Much Does Corcept Therapeutics Make?

Is Corcept Therapeutics Growing As A Company?

  • What Is Corcept Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.39%
  • What Is Corcept Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.28%

Corcept Therapeutics Stock Price Performance

What Is Corcept Therapeutics 52-Week High & Low?

Corcept Therapeutics Price To Free Cash Flow

Is It Risky To Buy Corcept Therapeutics?

Is Corcept Therapeutics Cash Flow Positive?

  • What Is CORT Cash Flow From Operations?
    Cash flow from operations (TTM) is $123.7M
  • What Is Corcept Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$5.8M
  • What Is Corcept Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$161.7M

Corcept Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CORT return on invested capital is 24.86%
  • What Is Corcept Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 20.25%
  • What Is CORT Return On Equity?
    ROE is a measure of profitability and is 24.86%

Corcept Therapeutics Earnings Date & Stock Price

Corcept Therapeutics Competitors

Corcept Therapeutics Dividend Yield

Corcept Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 28% 34.74%
Revenue: 39.15% 5.53%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 67.60
Upside from Last Price: 48.8%

Major Shareholders

  • How many CORT shares are owned by institutional investors?
    130.8M CORT shares are owned by institutional investors
  • How many CORT shares are owned by insiders?
    8.5M CORT shares are owned by insiders